TWI822711B - 非對稱ｐｃｒ方法、引子及套組 - Google Patents
非對稱ｐｃｒ方法、引子及套組 Download PDFInfo
- Publication number
- TWI822711B TWI822711B TW107141708A TW107141708A TWI822711B TW I822711 B TWI822711 B TW I822711B TW 107141708 A TW107141708 A TW 107141708A TW 107141708 A TW107141708 A TW 107141708A TW I822711 B TWI822711 B TW I822711B
- Authority
- TW
- Taiwan
- Prior art keywords
- primer
- region
- pcr
- sample
- temperature
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 171
- 238000007846 asymmetric PCR Methods 0.000 title abstract description 27
- 230000003321 amplification Effects 0.000 claims abstract description 25
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 25
- 238000003752 polymerase chain reaction Methods 0.000 claims description 110
- 150000007523 nucleic acids Chemical class 0.000 claims description 70
- 239000002773 nucleotide Substances 0.000 claims description 70
- 125000003729 nucleotide group Chemical group 0.000 claims description 70
- 108020004707 nucleic acids Proteins 0.000 claims description 69
- 102000039446 nucleic acids Human genes 0.000 claims description 69
- 239000000523 sample Substances 0.000 claims description 68
- 238000006243 chemical reaction Methods 0.000 claims description 50
- 230000000295 complement effect Effects 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 37
- 108091093088 Amplicon Proteins 0.000 claims description 32
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 16
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 16
- 238000004925 denaturation Methods 0.000 claims description 15
- 230000036425 denaturation Effects 0.000 claims description 15
- 239000012472 biological sample Substances 0.000 claims description 12
- 230000027455 binding Effects 0.000 claims description 11
- 239000012807 PCR reagent Substances 0.000 claims description 9
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 230000001351 cycling effect Effects 0.000 claims description 5
- 230000007613 environmental effect Effects 0.000 claims description 5
- 210000002700 urine Anatomy 0.000 claims description 5
- 206010036790 Productive cough Diseases 0.000 claims description 4
- 210000003802 sputum Anatomy 0.000 claims description 4
- 208000024794 sputum Diseases 0.000 claims description 4
- 238000005382 thermal cycling Methods 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 3
- 108020000949 Fungal DNA Proteins 0.000 claims description 2
- 238000007403 mPCR Methods 0.000 claims description 2
- 239000003330 peritoneal dialysis fluid Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 27
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 12
- 238000009396 hybridization Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 4
- 102100031780 Endonuclease Human genes 0.000 description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 4
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 3
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 3
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 3
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- LLTDOAPVRPZLCM-UHFFFAOYSA-O 4-(7,8,8,16,16,17-hexamethyl-4,20-disulfo-2-oxa-18-aza-6-azoniapentacyclo[11.7.0.03,11.05,9.015,19]icosa-1(20),3,5,9,11,13,15(19)-heptaen-12-yl)benzoic acid Chemical compound CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)[NH+]=4)(C)C)=CC3=3)S(O)(=O)=O)S(O)(=O)=O)=C1C=C2C=3C1=CC=C(C(O)=O)C=C1 LLTDOAPVRPZLCM-UHFFFAOYSA-O 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229930183912 Cytidylic acid Natural products 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241001424413 Lucia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000205160 Pyrococcus Species 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 241000205188 Thermococcus Species 0.000 description 2
- 241000204673 Thermoplasma acidophilum Species 0.000 description 2
- 241000589500 Thermus aquaticus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 210000004910 pleural fluid Anatomy 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001138 tear Anatomy 0.000 description 2
- LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
- SJQRQOKXQKVJGJ-UHFFFAOYSA-N 5-(2-aminoethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1S(O)(=O)=O SJQRQOKXQKVJGJ-UHFFFAOYSA-N 0.000 description 1
- NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000588625 Acinetobacter sp. Species 0.000 description 1
- 241001147825 Actinomyces sp. Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000701897 Bacillus virus B103 Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 201000005019 Chlamydia pneumonia Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000158508 Corynebacterium amycolatum Species 0.000 description 1
- ZWIADYZPOWUWEW-UHFFFAOYSA-N Cytidine 5'-diphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-UHFFFAOYSA-N 0.000 description 1
- PCDQPRRSZKQHHS-UHFFFAOYSA-N Cytidine 5'-triphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-UHFFFAOYSA-N 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 241000567769 Isurus oxyrinchus Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 241000227653 Lycopersicon Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000211181 Manta Species 0.000 description 1
- 241000589496 Meiothermus ruber Species 0.000 description 1
- 241001302042 Methanothermobacter thermautotrophicus Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 241000186367 Mycobacterium avium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 241000187681 Nocardia sp. Species 0.000 description 1
- 208000026681 Paratuberculosis Diseases 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 241000142787 Pneumocystis jirovecii Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001148023 Pyrococcus abyssi Species 0.000 description 1
- 241000205156 Pyrococcus furiosus Species 0.000 description 1
- 241000205192 Pyrococcus woesei Species 0.000 description 1
- 241000531138 Pyrolobus fumarii Species 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000205098 Sulfolobus acidocaldarius Species 0.000 description 1
- 241000205091 Sulfolobus solfataricus Species 0.000 description 1
- 241000589498 Thermus filiformis Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZWIADYZPOWUWEW-ZAKLUEHWSA-N cytidine-5'-diphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO[P@](O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-ZAKLUEHWSA-N 0.000 description 1
- PCDQPRRSZKQHHS-ZAKLUEHWSA-N cytidine-5'-triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-ZAKLUEHWSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- NFGXHKASABOEEW-LDRANXPESA-N methoprene Chemical compound COC(C)(C)CCCC(C)C\C=C\C(\C)=C\C(=O)OC(C)C NFGXHKASABOEEW-LDRANXPESA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 208000030773 pneumonia caused by chlamydia Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/131—Modifications characterised by incorporating a restriction site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/151—Modifications characterised by repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/107—Temperature of melting, i.e. Tm
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/107—Probe or oligonucleotide ligation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Bridges Or Land Bridges (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Joining Of Glass To Other Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/820,475 US10513730B2 (en) | 2017-11-22 | 2017-11-22 | Asymmetric PCR methods, primers and kits |
| US15/820,475 | 2017-11-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201925480A TW201925480A (zh) | 2019-07-01 |
| TWI822711B true TWI822711B (zh) | 2023-11-21 |
Family
ID=64559658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107141708A TWI822711B (zh) | 2017-11-22 | 2018-11-22 | 非對稱ｐｃｒ方法、引子及套組 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10513730B2 (https=) |
| EP (1) | EP3714065A1 (https=) |
| JP (1) | JP7334154B2 (https=) |
| KR (1) | KR20200088447A (https=) |
| CN (1) | CN111727261B (https=) |
| AU (1) | AU2018373766A1 (https=) |
| BR (1) | BR112020009782A2 (https=) |
| CA (1) | CA3082426A1 (https=) |
| IL (1) | IL274638B2 (https=) |
| MX (1) | MX2020005245A (https=) |
| MY (1) | MY200344A (https=) |
| PH (1) | PH12020550654A1 (https=) |
| RU (1) | RU2767061C2 (https=) |
| SG (1) | SG11202004284PA (https=) |
| TW (1) | TWI822711B (https=) |
| WO (1) | WO2019101796A1 (https=) |
| ZA (1) | ZA202002570B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022000628A (es) | 2019-07-19 | 2022-03-11 | Safeguard Biosystems Holdings Ltd | Deteccion de secuencias genomicas utilizando combinaciones de sondas, moleculas de sonda y arrays que comprenden las sondas para la deteccion especifica de organismos. |
| CN113046420B (zh) * | 2019-12-26 | 2022-10-04 | 厦门大学 | 一种不对称扩增多个靶核酸的方法 |
| CN113046421B (zh) * | 2019-12-26 | 2022-09-30 | 厦门大学 | 一种不对称扩增靶核酸的方法 |
| JP2024504966A (ja) | 2021-01-20 | 2024-02-02 | セイフガード バイオシステムズ ホールディングズ リミテッド | 改善されたゲノム配列検出およびそのためのプローブ分子 |
| CN116745434A (zh) | 2021-01-20 | 2023-09-12 | 保障生物系统控股有限公司 | 基因组序列的改进的检测及其探针分子 |
| CN115747328A (zh) * | 2022-08-19 | 2023-03-07 | 福建师范大学 | 一种提高单链dna产量和改善产物比例的方法 |
| CN121464225A (zh) * | 2023-06-08 | 2026-02-03 | 威廉马歇莱思大学 | 被配置用于具有高动态范围的含核酸样品的高通量探询的方法和试剂盒 |
| CN120138110B (zh) * | 2025-03-14 | 2026-04-07 | 湖南大地同年生物科技有限公司 | 多重pcr检测反应中代替高温变性产生单链的方法和提高多重pcr产物液相杂交检测灵敏性和准确性的方法及配套的试剂盒 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1629305A (zh) * | 2004-08-26 | 2005-06-22 | 北京博奥生物芯片有限责任公司 | 一种不对称pcr扩增方法及其专用引物与应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5066584A (en) | 1988-09-23 | 1991-11-19 | Cetus Corporation | Methods for generating single stranded dna by the polymerase chain reaction |
| US7435541B2 (en) * | 2000-05-23 | 2008-10-14 | Sequenom, Inc. | Restriction enzyme genotyping |
| US6887664B2 (en) * | 2000-06-06 | 2005-05-03 | Applera Corporation | Asynchronous primed PCR |
| AUPS076802A0 (en) * | 2002-02-26 | 2002-03-21 | Commonwealth Scientific And Industrial Research Organisation | Selective nucleic acid amplification |
| WO2004068112A2 (en) * | 2003-01-28 | 2004-08-12 | Gorilla Genomics, Inc. | Hairpin primer amplification |
| JP4322554B2 (ja) * | 2003-05-19 | 2009-09-02 | 株式会社ニチレイフーズ | Ｄｎａ増幅反応の効率向上方法 |
| CN100494399C (zh) * | 2003-06-30 | 2009-06-03 | 清华大学 | 一种基于dna芯片的基因分型方法及其应用 |
| ES2665690T3 (es) | 2007-02-02 | 2018-04-26 | Genera Biosystems Limited | Generación de moléculas de ácido nucleico |
| CN103459612A (zh) * | 2010-12-03 | 2013-12-18 | 布兰代斯大学 | 用于检测野生型群体中的核酸突变体的方法和试剂盒 |
| WO2014052487A1 (en) * | 2012-09-28 | 2014-04-03 | Cepheid | Two-primer pcr for microrna multiplex assay |
| WO2014160059A1 (en) * | 2013-03-13 | 2014-10-02 | Gen9, Inc. | Compositions and methods for synthesis of high fidelity oligonucleotides |
| NO337188B1 (no) * | 2013-04-08 | 2016-02-08 | Niva | COMPAS-PCR fremgangsmåte og fremgangsmåter for påvisning, identifisering eller overvåking av laksearter, kit, samt anvendelse av metoden og kit |
| CA2911303C (en) * | 2013-05-07 | 2021-02-16 | Micronics, Inc. | Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions |
| CN104293794B (zh) | 2014-09-24 | 2017-04-12 | 南方医科大学 | 一种与β‑淀粉样前体蛋白裂解酶1特异性结合的核酸适配子及其应用 |
| EP3181700A1 (en) | 2015-12-18 | 2017-06-21 | Safeguard Biosystems Holdings Ltd. | Three-dimensional polymer networks with channels situated therein |
| EP3199629A1 (en) | 2016-01-30 | 2017-08-02 | Safeguard Biosystems Holdings Ltd. | Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms |
-
2017
- 2017-11-22 US US15/820,475 patent/US10513730B2/en active Active
-
2018
- 2018-11-21 KR KR1020207018029A patent/KR20200088447A/ko active Pending
- 2018-11-21 BR BR112020009782-9A patent/BR112020009782A2/pt not_active Application Discontinuation
- 2018-11-21 US US16/765,601 patent/US20200308629A1/en not_active Abandoned
- 2018-11-21 WO PCT/EP2018/082086 patent/WO2019101796A1/en not_active Ceased
- 2018-11-21 MX MX2020005245A patent/MX2020005245A/es unknown
- 2018-11-21 JP JP2020528180A patent/JP7334154B2/ja active Active
- 2018-11-21 CA CA3082426A patent/CA3082426A1/en active Pending
- 2018-11-21 IL IL274638A patent/IL274638B2/en unknown
- 2018-11-21 AU AU2018373766A patent/AU2018373766A1/en not_active Abandoned
- 2018-11-21 SG SG11202004284PA patent/SG11202004284PA/en unknown
- 2018-11-21 MY MYPI2020002329A patent/MY200344A/en unknown
- 2018-11-21 EP EP18811474.8A patent/EP3714065A1/en active Pending
- 2018-11-21 CN CN201880075613.8A patent/CN111727261B/zh active Active
- 2018-11-21 RU RU2020119664A patent/RU2767061C2/ru active
- 2018-11-22 TW TW107141708A patent/TWI822711B/zh active
-
2020
- 2020-05-08 ZA ZA2020/02570A patent/ZA202002570B/en unknown
- 2020-05-18 PH PH12020550654A patent/PH12020550654A1/en unknown
-
2025
- 2025-04-07 US US19/171,538 patent/US20250290125A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1629305A (zh) * | 2004-08-26 | 2005-06-22 | 北京博奥生物芯片有限责任公司 | 一种不对称pcr扩增方法及其专用引物与应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3082426A1 (en) | 2019-05-31 |
| US20200308629A1 (en) | 2020-10-01 |
| US20250290125A1 (en) | 2025-09-18 |
| US20190153508A1 (en) | 2019-05-23 |
| RU2020119664A (ru) | 2021-12-23 |
| AU2018373766A1 (en) | 2020-05-28 |
| IL274638B2 (en) | 2025-03-01 |
| IL274638A (en) | 2020-06-30 |
| CN111727261A (zh) | 2020-09-29 |
| IL274638B1 (en) | 2024-11-01 |
| KR20200088447A (ko) | 2020-07-22 |
| BR112020009782A2 (pt) | 2020-10-13 |
| JP2021503903A (ja) | 2021-02-15 |
| EP3714065A1 (en) | 2020-09-30 |
| MX2020005245A (es) | 2020-08-24 |
| RU2020119664A3 (https=) | 2021-12-23 |
| RU2767061C2 (ru) | 2022-03-16 |
| MY200344A (en) | 2023-12-20 |
| SG11202004284PA (en) | 2020-06-29 |
| US10513730B2 (en) | 2019-12-24 |
| TW201925480A (zh) | 2019-07-01 |
| CN111727261B (zh) | 2024-10-29 |
| PH12020550654A1 (en) | 2021-04-19 |
| ZA202002570B (en) | 2021-08-25 |
| JP7334154B2 (ja) | 2023-08-28 |
| WO2019101796A1 (en) | 2019-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI822711B (zh) | 非對稱ｐｃｒ方法、引子及套組 | |
| US9057110B2 (en) | Method for direct amplification from crude nucleic acid samples | |
| CN103608467B (zh) | 用于核酸的振荡扩增反应 | |
| CN107849603B (zh) | 利用有限核苷酸组成的引物扩增 | |
| JP6970205B2 (ja) | Ｄｎａおよびｒｎａの同時濃縮を含むプライマー伸長標的濃縮およびそれに対する向上 | |
| JP5938348B2 (ja) | 反応特異性の増加のための非標準塩基を含む増幅プライマー | |
| CN104093850B (zh) | 用于减少非特异性核酸扩增的方法和试剂盒 | |
| MX2007010875A (es) | Oligonucleiotidos de especifidad dual y procesos que hacen uso de oligonucleotidos de especificidad dual. | |
| JP2022518917A (ja) | 核酸の検出方法及びプライマーの設計方法 | |
| Dada et al. | Polymerase chain reaction | |
| KR102106040B1 (ko) | 자가혈당측정기를 활용한 표적핵산 검출방법 | |
| EP2935622A1 (en) | Nucleic acid amplification method | |
| KR20240152864A (ko) | 고- 및 저-Tm 프라이머를 사용하는 베이스 2 초과의 지수적 베이스의 핵산 증폭 | |
| Kanu Jain et al. | Polymerase Chain Reaction: A Powerful Diagnostic and Research Tool |